about
Design Rationale and Development Approach for Pegfilgrastim as a Long-Acting Granulocyte Colony-Stimulating FactorPotentiation of the anti-tumour effects of Photofrin-based photodynamic therapy by localized treatment with G-CSFG-CSFR ubiquitination critically regulates myeloid cell survival and proliferation.Filgrastim improves survival in lethally irradiated nonhuman primatesA glycosylated recombinant human granulocyte colony stimulating factor produced in a novel protein production system (AVI-014) in healthy subjects: a first-in human, single dose, controlled study.Peripheral blood stem cell mobilization: new regimens, new cells, where do we standChemokine-mobilized adult stem cells; defining a better hematopoietic graft.Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and 'emergency' hematopoiesis.Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection.Pharmacokinetic profiles of a biosimilar filgrastim and Amgen filgrastim: results from a randomized, phase I trialGranulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysisComparison of the pharmacodynamic profiles of a biosimilar filgrastim and Amgen filgrastim: results from a randomized, phase I trialGranulocyte colony-stimulating factor (G-CSF) positive effects on muscle fiber degeneration and gait recovery after nerve lesion in MDX mice.Biophysical characterization of Met-G-CSF: effects of different site-specific mono-pegylations on protein stability and aggregation.Homodimeric cross-over structure of the human granulocyte colony-stimulating factor (GCSF) receptor signaling complex.Hematopoietic cytokines.Spontaneous circulation of myeloid-lymphoid-initiating cells and SCID-repopulating cells in sickle cell crisis.mom identifies a receptor for the Drosophila JAK/STAT signal transduction pathway and encodes a protein distantly related to the mammalian cytokine receptor family.A variable immunoreceptor in a subpopulation of human neutrophils.Preclinical and clinical phase I studies of a new recombinant Filgrastim (BK0023) in comparison with Neupogen®G-CSF influences mouse skeletal muscle development and regeneration by stimulating myoblast proliferation.Hematopoietic properties of granulocyte colony-stimulating factor/immunoglobulin (G-CSF/IgG-Fc) fusion proteins in normal and neutropenic rodents.Phenotypic and functional comparison of mobilized peripheral blood versus umbilical cord blood megakaryocyte populations.Interpretation of transit compartments pharmacodynamic models as lifespan based indirect response modelsThe effect of granulocyte-colony stimulating factor on rotator cuff healing after injury and repair.Cell biology and clinical promise of G-CSF: immunomodulation and neuroprotection.Stem cell factor and granulocyte colony-stimulating factor reduce β-amyloid deposits in the brains of APP/PS1 transgenic miceEthical problems of evaluating a new treatment for melioidosis.Neutrophil elastase in cyclic and severe congenital neutropenia.Fully Synthetic Granulocyte Colony-Stimulating Factor Enabled by Isonitrile-Mediated Coupling of Large, Side-Chain-Unprotected PeptidesPulmonary toxicity after granulocyte colony-stimulating factor-combined chemotherapy for non-Hodgkin's lymphoma.G-CSF-activated STAT3 enhances production of the chemokine MIP-2 in bone marrow neutrophils.Supportive therapy in medical therapy of head and neck tumors.Granulocyte colony-stimulating factor (G-CSF) transiently suppresses mitogen-stimulated T-cell proliferative response.Control of myeloid-specific integrin alpha Mbeta 2 (CD11b/CD18) expression by cytokines is regulated by Stat3-dependent activation of PU.1.Real-world impact of granulocyte-colony stimulating factor on febrile neutropeniaTemporal and geographic variation in the use of hematopoietic growth factors in older women receiving breast cancer chemotherapy: findings from a large population-based cohortEstablishing a murine model of the hematopoietic syndrome of the acute radiation syndromeAssignment of the gene locus for severe congenital neutropenia to chromosome 1q22 in the original Kostmann family from Northern Sweden.A phase III, randomized, non-inferiority study comparing the efficacy and safety of biosimilar filgrastim versus originator filgrastim for chemotherapy-induced neutropenia in breast cancer patients.
P2860
Q27004054-547BBF7F-B24B-492B-B6B1-7566D2067457Q28344188-1B276303-A0E1-4100-9CF2-925A0C07EC85Q33377020-59F8802D-20EB-443B-8BD7-449D3919EF95Q33390547-6855A7ED-9C7B-4F92-8EAE-73CBC7173EFCQ33403643-FCB3694C-D85D-4385-8B7F-E4515E05C640Q33589591-7250C150-AF1A-425A-98FB-7BFCF149C4D1Q33623545-B971BB3C-6F05-4DDA-84F1-905BF5EFC142Q33780538-BA01F512-7833-4BD7-9D13-CE2111AE1E4FQ33981858-2CDDDAFF-F27D-4488-93C8-31767A95015BQ34013208-27494B73-761B-4541-B616-997EE81C60ECQ34029496-44E55669-644B-43CB-BD25-EA7A53743DE9Q34077184-247712A6-6E95-4C56-8BAA-867AF805189EQ34300608-BB86ECF0-2C0E-4967-A535-AE21F786D3CCQ34384451-24A5BB59-0051-45A5-A3C2-D9DAA5A8A715Q34480299-40C15AFC-D1CB-4D2A-A8D6-C3A1A9F62188Q34734185-F0670060-E5E4-4D8A-AE99-F39EBACA6916Q34967767-C770394B-A198-4BFD-8ABA-7D6A4F5ACF30Q35005371-6331F960-D0B2-4CFF-BEE7-7031EA555196Q35080689-3751E8B5-A8E5-43CD-8C83-5CA76B638FBBQ35098849-AEE93ECE-5751-454F-8E03-830CC44CAEB6Q35102238-C2CAE08D-F7C9-46F3-B2C8-62D36F2C4DA9Q35122746-E289391C-E71A-4A2D-B568-A182E518C341Q35171198-114E479F-6ED5-4A92-B241-1384DF4AF747Q35226129-4A238CF5-31F1-47F8-84AF-86BD6FC8A477Q35268244-79FD82E6-B899-4773-8F02-C55614E947C8Q35459801-20E9F5CC-AE38-46F9-B4BA-FAFC25958439Q35579218-BAE2D668-3E7A-40C3-A68B-624E8A4FB03EQ35596349-1BBA87E4-79F1-4620-8FF1-0225804B1FEEQ35642863-3303CA7D-9615-40A3-BAE2-9C02B8C5DCA9Q36198586-84F258E3-108D-44F2-9A36-23BCE5E1CBADQ36292887-4A51E5B3-2351-4EA8-B79B-59943F9EB71AQ36410811-3684A725-EF13-471F-A11D-ECD881BAF510Q36529853-BD02B3BA-3DD5-4188-A94B-320A9C9F2683Q36620210-36DC0460-57FF-4FBF-BD9B-EA4E18A61138Q36664602-3CB399B5-BC44-4608-BE56-E828BC313FFCQ36897773-47FD65BD-0D11-45E5-B999-73EF7336F89AQ36949179-E1948125-5D97-4C91-A021-C32846C61C37Q37094589-FBDC567B-B319-4634-9881-20F9D7AA750EQ37292153-6B662FDF-DC3D-4856-B562-298BE0B9E2ABQ37320677-37AE372E-A916-45FA-BAC4-C94F8E9CBA15
P2860
description
1996 nî lūn-bûn
@nan
1996 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Filgrastim (r-metHuG-CSF): the first 10 years.
@ast
Filgrastim (r-metHuG-CSF): the first 10 years.
@en
Filgrastim
@nl
type
label
Filgrastim (r-metHuG-CSF): the first 10 years.
@ast
Filgrastim (r-metHuG-CSF): the first 10 years.
@en
Filgrastim
@nl
prefLabel
Filgrastim (r-metHuG-CSF): the first 10 years.
@ast
Filgrastim (r-metHuG-CSF): the first 10 years.
@en
Filgrastim
@nl
P2093
P1433
P1476
Filgrastim (r-metHuG-CSF): the first 10 years
@en
P2093
P304
P407
P577
1996-09-01T00:00:00Z